To address the hypothesis that MMTV plays a role in the development of inflammation in the IL-10−/− mouse model, we employed a cART regimen previously shown to ameliorate MMTV cholangitis in the NOD.c3c4 autoimmune biliary disease model of primary biliary cholangitis [21]. Here, IL10 is linked to biliary liver cirrhosis.